Takasaki, Japan

Kazumasa Hasegawa




Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 101(Granted Patents)


Location History:

  • Gunma-ken, JP (2013)
  • Takasaki, JP (2004 - 2015)
  • Tokyo, JP (2017)

Company Filing History:


Years Active: 2004-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kazumasa Hasegawa: Innovator in Cancer Treatment

Introduction

Kazumasa Hasegawa is a prominent inventor based in Takasaki, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies. With a total of six patents to his name, Hasegawa's work focuses on creating targeted therapies that specifically attack cancer cells.

Latest Patents

One of Hasegawa's latest patents involves the development of an Anti-CD98 antibody. This human antibody or its functional fragment has a specific binding ability to CD98, which is derived from the cell membrane of cancer cells. The antibody forms a complex with a protein that has amino acid transporter activity, such as LAT1. This innovative approach allows the antibody to bind to CD98 in a dimer form with LAT1 on the surface of cancer cells. It specifically targets cancer cells expressing CD98 through the immune system by mechanisms like Antibody-Dependent Cellular Cytotoxicity (ADCC) or Complement-Dependent Cytotoxicity (CDC). Furthermore, it inhibits the amino acid uptake of cancer cells via LAT1, effectively suppressing their growth. This invention provides a preventive and therapeutic agent for various cancers, ensuring specificity to cancer cells while minimizing side effects.

Career Highlights

Kazumasa Hasegawa has worked with notable companies in the pharmaceutical and beverage industries. He has been associated with Kyowa Hakko Kirin Co., Limited and Kirin Beer Company. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.

Collaborations

Hasegawa has collaborated with esteemed colleagues, including Tomoyuki Tahara and Yoshikatsu Kanai. Their combined efforts have further advanced the research and development of effective cancer therapies.

Conclusion

Kazumasa Hasegawa's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work exemplifies the potential of targeted therapies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…